SyntheMed, Inc. is a biomaterials company dedicated to developing and marketing proprietary polymer products used to prevent or reduce adhesions that may form in a a broad range of surgical procedures.
REPEL-CV®Adhesion Barrier, our lead product for cardiac surgery, is a bioresorbable film that reduces the severity of post-operative adhesion formation.
Our proprietary bioresorbable technology is based on a group of polymers that are bioresorbable, flexible, conformable and strong ... properties that make them suitable for tailoring to a variety of applications.
Our product development efforts are continually exploring ways in which our technology will produce innovative, cost-effective medical devices that benefit surgeons and their patients.